Skip to main content

Table 4 Effect of different antibiotic use strategies on the prognosis of AP

From: Effect of early antibiotic treatment strategy on prognosis of acute pancreatitis

   

Antibiotics

None

   

Carbapenem

Third generation cephalosporin

Quinolones

 

Biliary Pancreatitis

      

SAP

 

n = 88

n = 17

 

n = 11

Laparotomy,(%)

16(18.2)

5(31.6)

 

8(72.7)*â–´

Length of hospital stay, days

45.8 ± 29.5

71.1 ± 45.5#

 

91.0 ± 49.4*

In-hospital mortality,(%)

9 (10.2)

5 (26.3)#

 

2(18.2)

AKI,n(%)

39(44.3)

8(42.1)

 

6(54.5)

CRRT,n(%)

9(10.2)

1(5.3)

 

3(27.3)

MV,n(%)

41(46.6)

11(57.9)

 

10(90.9)*

MSAP

 

n = 10

n = 187

n = 15

n = 51

Length of hospital stay, days

32.6 ± 14.6

17.8 ± 10.9

14.2 ± 5.9

36.6 ± 18.4*▴▪

In-hospital mortality,(%)

0

1(0.5)

0

2(3.9)â–´

AKI,n(%)

1(10.0)

11(5.9)

1(0.5)

5(9.8)

MAP

 

n = 2

n = 50

n = 17

n = 204

Length of hospital stay, days

7.0 ± 1.4

9.3 ± 4.0

8.5 ± 3.2

12.2 ± 5.0▪

Hyperlipidemic pancreatitis

SAP

 

n = 20

n = 65

 

n = 5

Laparotomy,(%)

3 (15.0)

4 (6.2)

 

1(20.0)

Length of hospital stay, days

47.1 ± 25.2

43.5 ± 23.8

 

54.0 ± 39.1

In-hospital mortality,(%)

1(5.0)

5(7.7)

 

0

AKI, n(%)

11(55.0)

24(36.9)

 

0*

CRRT,n(%)

15(17.6)

10(15.4)

 

0

MV,n(%)

41(46.6)

11(57.9)

 

10(90.9)*

MSAP

 

n = 7

n = 66

n = 5

n = 46

Length of hospital stay, days

41.6 ± 21.0

30.1 ± 15.3

25.8 ± 10.0

21.3 ± 9.9▴

In-hospital mortality,(%)

0

1(1.4)

0

0

AKI, n(%)

1(14.3)

3(4.5)

0

3(6.5)

MAP

 

n = 1

n = 42

n = 5

n = 90

Length of hospital stay, days

–

8.5 ± 3.2

14.0 ± 4.1

11.1 ± 4.4

Alcoholic pancreatitis

SAP

 

n = 9

n = 4

 

n = 2

Laparotomy,(%)

2(22.2)

0

 

0(0)

Length of hospital stay, days

65.6 ± 65.1

29.2 ± 10.9

 

52.5 ± 26.1▴

In-hospital mortality,(%)

3(33.3)

0

 

0(0)

AKI, n(%)

4(44.4)

1(25.0)

 

2(100)

CRRT,n(%)

2(22.2)

0

 

0(0)

MV,n(%)

7(83.3)

2(50.0)

 

1(50.0)

MSAP

 

n = 0

n = 13

n = 2

n = 10

Length of hospital stay, days

–

28.0 ± 12.4

23.0 ± 15.5

0.333

In-hospital mortality,(%)

–

1(7.6)

1(50.0)

1

AKI, n(%)

–

1(7.6)

1(50.0)

1

MAP

 

n = 1

n = 7

n = 1

n = 22

Length of hospital stay, days

–

18.0 ± 5.7

–

12.2 ± 5.0

Other

SAP

 

n = 10

n = 12

 

n = 1

Laparotomy,(%)

3(33.3)

1(8.3%)

 

0(0)

Length of hospital stay, days

47.25 ± 40.49

45.69 ± 27.16

 

–

In-hospital mortality,(%)

0(0.0)

1(8.3%)

 

0(0)

AKI, n(%)

7(70.0)

6(50.0)

 

2(100)

CRRT,n(%)

2(20.2)

0

 

0(0.0)

MV,n(%)

8(80.0)

9(75.0)

 

1(50)

MSAP

 

n = 0

n = 17

n = 0

n = 0

Length of hospital stay, days

–

–

–

–

In-hospital mortality,(%)

–

–

–

–

AKI, n(%)

–

–

–

–

MAP

 

n = 3

n = 2

n = 1

n = 10

Length of hospital stay, days

21.3 ± 6.0

18.0 ± 5.7

–

12.0 ± 5.3

  1. *Comparison of the carbapenem group with the no antibiotic group, P < 0.05; ▴:Triple cephalosporin combined with metronidazole versus no antibiotic group, P < 0.05;#:Comparison of carbapenems and triple cephalosporins combined with metronidazole group, P < 0.05;▪:Quinolone combined with metronidazole versus no antibiotic group, P < 0.05